|
Market Cap (19-May) $95,239,352 (971st) |
Close (9-Dec) $1.04 |
Volume (9-Dec) 0 |
Shortsold (3-Dec) 50,000 (0.05%) (513th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.144 |
BD1 released this announcement to the ASX on 28 January 2021, 8:30. The announcement is not marked as price sensitive, and is 2 page(s) in length and 183.64kb in size.
You can view all announcements from BD1 and see how they appear on a price chart on the announcements page.
At the date of this announcement, BD1 was 0.010% short sold according to ASIC data. It was ranked the 568th most shorted stock on the ASX. It is now ranked as the 513th most shorted stock on the ASX with 0.054% of total shares short sold as of the latest reported data (03 December 2021).
| Other Recent Announcements from BD1 | |
|---|---|
| BARD1 Changes its Name to INOVIQ | 8 December 2021, 8:58 |
| Cleansing Notice - Issued of Four Shares - Resolution 5 AGM | 7 December 2021, 12:12 |
| Application for quotation of securities - BD1 | 7 December 2021, 12:06 |
| U.S. Patent Granted for NET Technology for Exosome Capture | 28 January 2021, 8:30 |
| Final Director's Interest Notice - Dr Irminger-Finger | 15 January 2021, 14:34 |
| Dr Irminger steps down from Board, continues as Consultant | 15 January 2021, 9:43 |
| Change of Director's Interest Notice - Cumming | 8 December 2020, 10:08 |
You must be logged in to post a reply.
BARD1 Life Sciences 